TY  - GEN
AU  - Noel,Marcus
AU  - O'Reilly,Eileen M
AU  - Wolpin,Brian M
AU  - Ryan,David P
AU  - Bullock,Andrea J
AU  - Britten,Carolyn D
AU  - Linehan,David C
AU  - Belt,Brian A
AU  - Gamelin,Eric C
AU  - Ganguly,Bishu
AU  - Yin,Donghua
AU  - Joh,Tenshang
AU  - Jacobs,Ira A
AU  - Taylor,Carrie T
AU  - Lowery,Maeve A
TI  - Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma
SN  - 1573-0646
PY  - 2021///0601
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Aged
KW  - Albumins
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Pancreatic Ductal
KW  - Chemokine CCL2
KW  - antagonists & inhibitors
KW  - Cohort Studies
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Paclitaxel
KW  - Pancreatic Neoplasms
KW  - Prognosis
KW  - Pyrrolidines
KW  - Small Molecule Libraries
KW  - Tumor Microenvironment
KW  - drug effects
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10637-019-00830-3
ER  -